Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles

24 May 2017

Abstract excerpt

BACKGROUND: One of the various ovarian stimulation regimens used for in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycles is the use of recombinant follicle-stimulating hormone (rFSH) in combination with a gonadotrophin-releasing hormone (GnRH) analogue. GnRH analogues prevent premature luteinizing hormone (LH) surges. Since they deprive the growing follicles of LH, the question arises...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hypothalamic control of reproductive hormones
Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28537052
DOI: 10.1002/14651858.cd005070.pub3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cyclesPMID 28537052Read ↗

Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 yearsSemantic proximity Read ↗

Long-acting FSH versus daily FSH for women undergoing assisted reproductionSemantic proximity Read ↗

Effect of recombinant human gonadotrophins on human, bovine and murine oocyte meiosis, fertilization and embryonic development in vitroSemantic proximity Read ↗

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulationSemantic proximity Read ↗

Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndromeSemantic proximity Read ↗

The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centresSemantic proximity Read ↗

Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian hyperstimulation: A systematic review and meta-analysisSemantic proximity Read ↗

Clinical Assisted Reproduction: The Effect of Exogenous Luteinizing Hormone (LH) on Oocyte Viability: Evidence from a Comparative Study Using Recombinant Human Follicle-Stimulating Hormone (FSH) Alone or in Combination with Recombinant LH for Ovarian Stimulation in Pituitary-Suppressed Women Undergoing Assisted ReproductionSemantic proximity Read ↗

Timing ovulation for intrauterine insemination with a GnRH antagonistSemantic proximity Read ↗

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injectionSemantic proximity Read ↗

Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSHSemantic proximity Read ↗

Luteal phase support in assisted reproduction cyclesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.